Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities

NCT ID: NCT02147327

Last Updated: 2014-05-29

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 120 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2013-10-31
• Study Completion Date: 2014-05-31

Brief Summary

Cholecalciferol (vitamin D3) is a prohormone and its active form is 1,25 dihydroxycholecalciferol. This hormone has effect on both calcium, phosphorus and bone metabolism and also bone morrow, muscle, heart and immune system. For a long time, maternal low vitamin D level is a well known problem for our country and the level was reported as <10 ng/ml for 46-80% of mothers.The most prominent risk factor was determined as low socioeconomic status. Therefore, the level of 25-hydroxy-vitamin D is supposed to be in relation with several neonatal morbidities and maternal complications of pregnancy.

Conditions

Neonatal Hypocalcemia; Neonatal Sepsis

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Term or preterm newborns which are hospitalized in the Neonatal Intensive Care Unit of our hospital

Exclusion Criteria

• Preterm babies born before the 24. gestational week
• Babies with complex cardiac anomalies and/or dysmorphic features

• Maximum Eligible Age: 30 Minutes
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Zekai Tahir Burak Women's Health Research and Education Hospital

OTHER

Sponsor Role: lead

Responsible Party

birgul say

Fellow in Neonatology, Pediatrician

Responsibility Role: PRINCIPAL_INVESTIGATOR

Other Identifiers

sevit25D3

Identifier Type: -

Identifier Source: org_study_id